Direct Neutralization of Type III Effector Translocation by the Variable Region of a Monoclonal Antibody to Yersinia pestis LcrV

  • Maya I. Ivanov, Jim Hill, James B. Bliska
  • Clinical and Vaccine Immunology, March 2014, ASM Journals
  • DOI: 10.1128/cvi.00013-14

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

The following have contributed to this page: Professor James B Bliska

In partnership with: